Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2018 (2018), Article ID 8927281, 13 pages
https://doi.org/10.1155/2018/8927281
Review Article

Coronary Atherosclerosis Assessment by Coronary CT Angiography in Asymptomatic Diabetic Population: A Critical Systematic Review of the Literature and Future Perspectives

1Institute of Cardiovascular Disease, Department of Emergency and Organ Transplantation, University Hospital Policlinico of Bari, Bari, Italy
2Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy
3Section of Diagnostic Imaging, Interdisciplinary Department of Medicine, University Hospital Policlinico of Bari, Bari, Italy
4Centro Cardiologico Monzino, IRCCS, Milano, Italy
5CMO Torre Annunziata, Napoli, Italy

Correspondence should be addressed to Gianluca Pontone; ti.mfcc@enotnop.aculnaig

Received 30 June 2017; Accepted 2 December 2017; Published 15 January 2018

Academic Editor: Charbel Abi Khalil

Copyright © 2018 Andrea Igoren Guaricci et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. M. V. Narayan, J. P. Boyle, L. S. Geiss, J. B. Saaddine, and T. J. Thompson, “Impact of recent increase in incidence on future diabetes burden: U.S., 2005–2050,” Diabetes Care, vol. 29, no. 9, pp. 2114–2116, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. H. King, R. E. Aubert, and W. H. Herman, “Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections,” Diabetes Care, vol. 21, no. 9, pp. 1414–1431, 1998. View at Publisher · View at Google Scholar · View at Scopus
  3. D. M. Nathan, J. Meigs, and D. E. Singer, “The epidemiology of cardiovascular disease in type 2 diabetes mellitus: how sweet it is . . . or is it?” The Lancet, vol. 350, no. 1, pp. 4–9, 1997. View at Publisher · View at Google Scholar · View at Scopus
  4. W. B. Kannel and D. L. McGee, “Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study,” Diabetes Care, vol. 2, no. 2, pp. 120–126, 1979. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Sarwar, P. Gao, and S. R. Seshasai, “Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies,” The Lancet, vol. 375, no. 9733, pp. 2215–2222, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. J. S. Rana, A. Dunning, S. Achenbach et al., “Differences in prevalence, extent, severity, and prognosis of coronary artery disease among patients with and without diabetes undergoing coronary computed tomography angiography: results from 10,110 individuals from the CONFIRM (Coronary CT Angiography EvaluatioN for Clinical Outcomes): an InteRnational Multicenter Registry,” Diabetes Care, vol. 35, no. 8, pp. 1787–1794, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. E. Maffei, C. Martini, C. Tedeschi et al., “Diagnostic accuracy of 64-slice computed tomography coronary angiography in a large population of patients without revascularisation: registry data on the comparison between male and female population,” La Radiologia Medica, vol. 117, no. 1, pp. 6–18, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Pontone, D. Andreini, A. I. Guaricci et al., “The STRATEGY Study (Stress Cardiac Magnetic Resonance Versus Computed Tomography Coronary Angiography for the Management of Symptomatic Revascularized Patients): resources and Outcomes Impact,” Circulation: Cardiovascular Imaging, vol. 9, no. 10, Article ID 005171, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Pontone, M. G. Rabbat, and A. I. Guaricci, “Stress Computed Tomographic Perfusion,” Circulation: Cardiovascular Imaging, vol. 10, no. 4, p. e006324, 2017. View at Publisher · View at Google Scholar
  10. A. I. Guaricci, G. Pontone, N. D. Brunetti et al., “The presence of remodeled and mixed atherosclerotic plaques at coronary ct angiography predicts major cardiac adverse events — The café-pie study,” International Journal of Cardiology, vol. 215, pp. 325–331, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. E. Maffei, S. Seitun, C. Martini et al., “Prognostic value of computed tomography coronary angiography in patients with chest pain of suspected cardiac origin,” La Radiologia Medica, vol. 116, no. 5, pp. 690–705, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. “CT coronary angiography in patients with suspected angina due to coronary heart disease (SCOT-HEART): an open-label, parallel-group, multicentre trial,” The Lancet, vol. 385, no. 9985, pp. 2383–2391, 2015. View at Publisher · View at Google Scholar
  13. E. Maffei, M. Midiri, V. Russo et al., “Rationale, design and methods of CTCA-PRORECAD (Computed Tomography Coronary Angiography Prognostic Registry for Coronary Artery Disease): a multicentre and multivendor registry,” La Radiologia Medica, vol. 118, no. 4, pp. 591–607, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Andreini, E. Martuscelli, A. I. Guaricci et al., “Clinical recommendations on Cardiac-CT in 2015: a position paper of the Working Group on Cardiac-CT and Nuclear Cardiology of the Italian Society of Cardiology,” Journal of Cardiovascular Medicine, vol. 17, no. 2, pp. 73–84, 2016. View at Publisher · View at Google Scholar · View at Scopus
  15. L. J. Shaw, Y. Chandrashekhar, and J. Narula, “Risk Detection Among Asymptomatic Patients With Diabetes: is It Time for a Varied Approach?” JACC: Cardiovascular Imaging, vol. 9, no. 11, pp. 1362–1365, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. C. S. Fox, S. H. Golden, C. Anderson et al., “Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: a scientific statement from the American Heart Association and the American diabetes association,” Diabetes Care, vol. 38, no. 9, pp. 1777–1803, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Rydén, P. J. Grant, and S. D. Anker, “ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD),” European Heart Journal, vol. 34, no. 39, pp. 3035–3087, 2013. View at Publisher · View at Google Scholar
  18. K. Gu, C. C. Cowie, and M. I. Harris, “Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971–1993,” Diabetes Care, vol. 21, no. 7, pp. 1138–1145, 1998. View at Publisher · View at Google Scholar · View at Scopus
  19. S. M. Haffner, S. Lehto, T. Rönnemaa, K. Pyörälä, and M. Laakso, “Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction,” The New England Journal of Medicine, vol. 339, no. 4, pp. 229–234, 1998. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Lenfant, J. I. Cleeman, T. G. Ganiats et al., “Executive summary of the third report of the national cholesterol education program expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel iii),” Journal of American Medical Association, vol. 285, no. 19, pp. 2486–2497, 2001. View at Google Scholar
  21. S. Natarajan, Y. Liao, D. Sinha, G. Cao, D. L. McGee, and S. R. Lipsitz, “Sex differences in the effect of diabetes duration on coronary heart disease mortality,” JAMA Internal Medicine, vol. 165, no. 4, pp. 430–435, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. F. B. Hu, M. J. Stampfer, C. G. Solomon et al., “The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up,” JAMA Internal Medicine, vol. 161, no. 14, pp. 1717–1723, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. J. M. M. Evans, J. Wang, and A. D. Morris, “Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies,” British Medical Journal, vol. 324, no. 7343, pp. 939–942, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. O. Vaccaro, L. E. Eberly, J. D. Neaton, L. Yang, G. Riccardi, and J. Stamler, “Impact of diabetes and previous myocardial infarction on long-term survival: 25-Year mortality follow-up of primary screenees of the multiple risk factor intervention trial,” JAMA Internal Medicine, vol. 164, no. 13, pp. 1438–1443, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. U. Bulugahapitiya, S. Siyambalapitiya, J. Sithole, and I. Idris, “Is diabetes a coronary risk equivalent? Systematic review and meta-analysis: original Article: Epidemiology,” Diabetic Medicine, vol. 26, no. 2, pp. 142–148, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. J. S. Rana, J. Y. Liu, H. H. Moffet, M. Jaffe, and A. J. Karter, “Diabetes and Prior Coronary Heart Disease are Not Necessarily Risk Equivalent for Future Coronary Heart Disease Events,” Journal of General Internal Medicine, vol. 31, no. 4, pp. 387–393, 2016. View at Publisher · View at Google Scholar · View at Scopus
  27. D. C. Goff Jr, D. M. Lloyd-Jones, and G. Bennett, “ACC/AHA guideline on the assessment of cardiovascular risk,” Journal of the American College of Cardiology, vol. 63, no. 25, pp. 2935–2959, 2013. View at Google Scholar
  28. T. Y. Goraya, C. L. Leibson, P. J. Palumbo et al., “Coronary atherosclerosis in diabetes mellitus: a population-based autopsy study,” Journal of the American College of Cardiology, vol. 40, no. 5, pp. 946–953, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. J. J. Bax, S. E. Inzucchi, R. O. Bonow, J. D. Schuijf, M. R. Freeman, and E. J. Barrett, “Cardiac imaging for risk stratification in diabetes,” Diabetes Care, vol. 30, no. 5, pp. 1295–1304, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. G. Ambepityia, P. G. Kopelman, D. Ingram, M. Swash, P. G. Mills, and A. D. Timmis, “Exertional myocardial ischemia in diabetes: a quantitative analysis of anginal perceptual threshold and the influnce of autonomic function,” Journal of the American College of Cardiology, vol. 15, no. 1, pp. 72–77, 1990. View at Publisher · View at Google Scholar · View at Scopus
  31. S. M. Grundy, I. J. Benjamin, G. L. Burke et al., “Diabetes and cardiovascular disease: a statement for healthcare professionals from the american heart association,” Circulation, vol. 100, no. 10, pp. 1134–1146, 1999. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Elhendy, R. T. Van Domburg, D. Poldermans et al., “Safety and feasibility of dobutamine-atropine stress echocardiography for the diagnosis of coronary artery disease in diabetic patients unable to perform an exercise stress test,” Diabetes Care, vol. 21, no. 11, pp. 1797–1802, 1998. View at Publisher · View at Google Scholar · View at Scopus
  33. S. G. Sawada, T. Ryan, M. J. Conley, B. C. Corya, H. Feigenbaum, and W. F. Armstrong, “Prognostic value of a normal exercise echocardiogram,” American Heart Journal, vol. 120, no. 1, pp. 49–55, 1990. View at Publisher · View at Google Scholar · View at Scopus
  34. R. B. McCully, V. L. Roger, D. W. Mahoney et al., “Outcome after normal exercise echocardiography and predictors of subsequent cardiac events: follow-up of 1,325 patients,” Journal of the American College of Cardiology, vol. 31, no. 1, pp. 144–149, 1998. View at Publisher · View at Google Scholar · View at Scopus
  35. T. G. Hennessy, M. B. Codd, G. Kane, C. McCarthy, H. A. McCann, and D. D. Sugrue, “Evaluation of patients with diabetes mellitus for coronary artery disease using dobutamine stress echocardiography,” Coronary Artery Disease, vol. 8, no. 3-4, pp. 171–174, 1997. View at Publisher · View at Google Scholar · View at Scopus
  36. M. E. Griffin, K. Nikookam, M. M. Teh, H. McCann, N. M. O'Meara, and R. G. Firth, “Dobutamine stress echocardiography: false positive scans in proteinuric patients with type 1 diabetes mellitus at high risk of ischaemic heart disease,” Diabetic Medicine, vol. 15, no. 5, pp. 427–430, 1998. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Kamalesh, R. Matorin, and S. Sawada, “Prognostic value of a negative stress echocardiographic study in diabetic patients,” American Heart Journal, vol. 143, no. 1, pp. 163–168, 2002. View at Publisher · View at Google Scholar · View at Scopus
  38. D. McGuire and C. Granger, “Diabetes and ischemic heart disease,” American Heart Journal, vol. 138, no. 4, pp. s366–s375, 1999. View at Publisher · View at Google Scholar
  39. L. Cortigiani, R. Bigi, R. Sicari, P. Landi, F. Bovenzi, and E. Picano, “Prognostic value of pharmacological stress echocardiography in diabetic and nondiabetic patients with known or suspected coronary artery disease,” Journal of the American College of Cardiology, vol. 47, no. 3, pp. 605–610, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. N. Chaowalit, A. L. Arruda, R. B. McCully, K. R. Bailey, and P. A. Pellikka, “Dobutamine stress echocardiography in patients with diabetes mellitus: Enhanced prognostic prediction using a simple risk score,” Journal of the American College of Cardiology, vol. 47, no. 5, pp. 1029–1036, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. F. B. Sozzi, A. Elhendy, J. R. T. C. Roelandt et al., “Prognostic value of dobutamine stress echocardiography in patients with diabetes,” Diabetes Care, vol. 26, no. 4, pp. 1074–1078, 2003. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Giri, L. J. Shaw, D. R. Murthy et al., “Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease,” Circulation, vol. 105, no. 1, pp. 32–40, 2002. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Kamalesh, H. Feigenbaum, and S. Sawada, “Assessing Prognosis in Patients With Diabetes Mellitus-The Achilles' Heel of Cardiac Stress Imaging Tests?” American Journal of Cardiology, vol. 99, no. 7, pp. 1016–1019, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. J. M. Van Werkhoven, F. Cademartiri, S. Seitun et al., “Diabetes: prognostic value of CT coronary angiography - Comparison with a nondiabetic population,” Radiology, vol. 256, no. 1, pp. 83–92, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. J. Nadjiri, J. Hausleiter, S. Deseive et al., “Prognostic value of coronary CT angiography in diabetic patients: a 5-year follow up study,” The International Journal of Cardiovascular Imaging, vol. 32, no. 3, pp. 483–491, 2016. View at Publisher · View at Google Scholar · View at Scopus
  46. P. Blanke, C. Naoum, A. Ahmadi et al., “Long-Term Prognostic Utility of Coronary CT Angiography in Stable Patients With Diabetes Mellitus,” JACC: Cardiovascular Imaging, vol. 9, no. 11, pp. 1280–1288, 2016. View at Publisher · View at Google Scholar · View at Scopus
  47. J. A. Rumberger, D. B. Simons, L. A. Fitzpatrick, P. F. Sheedy, and R. S. Schwartz, “Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area: a histopathologic correlative study,” Circulation, vol. 92, no. 8, pp. 2157–2162, 1995. View at Publisher · View at Google Scholar · View at Scopus
  48. Y. Arad, K. J. Goodman, M. Roth, D. Newstein, and A. D. Guerci, “Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: the St. Francis heart study,” Journal of the American College of Cardiology, vol. 46, no. 1, pp. 158–165, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. R. Detrano, A. D. Guerci, J. J. Carr et al., “Coronary calcium as a predictor of coronary events in four racial or ethnic groups,” The New England Journal of Medicine, vol. 358, no. 13, pp. 1336–1345, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. E. Maffei, C. Martini, C. Tedeschi et al., “Diagnostic accuracy of 64-slice computed tomography coronary angiography in a large population of patients without revascularisation: registry data on the impact of calcium score,” La Radiologia Medica, vol. 116, no. 7, pp. 1000–1013, 2011. View at Publisher · View at Google Scholar · View at Scopus
  51. M. F. Piepoli, A. W. Hoes, C. Brotons, R. F. Hobbs, and U. Corra, “Main messages for primary care from the 2016 European Guidelines on cardiovascular disease prevention in clinical practice,” European Journal of General Practice, pp. 1–6, 2017. View at Publisher · View at Google Scholar
  52. M. J. Wolk, S. R. Bailey, J. U. Doherty et al., “Multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease. American College of Cardiology Foundation Appropriate Use Criteria Task Force,” Journal of the American College of Cardiology, vol. 63, no. 2, pp. 380–406, 2014. View at Google Scholar
  53. N. Wong, M. Sciammarella, and D. Polk, “The metabolic syndrome, diabetes and subclinical atherosclerosis assessed by coronary calcium,” ACC Current Journal Review, vol. 12, no. 5, p. 41, 2003. View at Publisher · View at Google Scholar
  54. D. A. Towler, M. Bidder, T. Latifi, T. Coleman, and C. F. Semenkovich, “Diet-induced diabetes activates an osteogenic gene regulatory program in the aortas of low density lipoprotein receptor-deficient mice,” The Journal of Biological Chemistry, vol. 273, no. 46, pp. 30427–30434, 1998. View at Publisher · View at Google Scholar · View at Scopus
  55. J. J. Bax, L. H. Young, R. L. Frye, R. O. Bonow, H. O. Steinberg, and E. J. Barrett, “Screening for coronary artery disease in patients with diabetes,” Diabetes Care, vol. 30, no. 10, pp. 2729–2736, 2007. View at Publisher · View at Google Scholar · View at Scopus
  56. D. V. Anand, E. Lim, D. Hopkins et al., “Risk stratification in uncomplicated type 2 diabetes: prospective evaluation of the combined use of coronary artery calcium imaging and selective myocardial perfusion scintigraphy,” European Heart Journal, vol. 27, no. 6, pp. 713–721, 2006. View at Publisher · View at Google Scholar · View at Scopus
  57. N. D. Wong, A. Rozanski, H. Gransar et al., “Metabolic syndrome and diabetes are associated with an increased likelihood of inducible myocardial ischemia among patients with subclinical atherosclerosis,” Diabetes Care, vol. 28, no. 6, pp. 1445–1450, 2005. View at Publisher · View at Google Scholar · View at Scopus
  58. P. Raggi, B. Cooil, C. Ratti, T. Q. Callister, and M. Budoff, “Progression of coronary artery calcium and occurrence of myocardial infarction in patients with and without diabetes mellitus,” Hypertension, vol. 46, no. 1, pp. 238–243, 2005. View at Publisher · View at Google Scholar · View at Scopus
  59. J. Yeboah, R. Erbel, J. C. Delaney et al., “Development of a new diabetes risk prediction tool for incident coronary heart disease events: the Multi-Ethnic Study of Atherosclerosis and the Heinz Nixdorf Recall Study,” Atherosclerosis, vol. 236, no. 2, pp. 411–417, 2014. View at Publisher · View at Google Scholar · View at Scopus
  60. M. J. Budoff, J. E. Hokanson, K. Nasir et al., “Progression of coronary artery calcium predicts all-cause mortality,” JACC: Cardiovascular Imaging, vol. 3, no. 12, pp. 1229–1236, 2010. View at Publisher · View at Google Scholar · View at Scopus
  61. P. Raggi, L. J. Shaw, D. S. Berman, and T. Q. Callister, “Prognostic value of coronary artery calcium screening in subjects with and without diabetes,” Journal of the American College of Cardiology, vol. 43, no. 9, pp. 1663–1669, 2004. View at Publisher · View at Google Scholar · View at Scopus
  62. R. A. Kronmal, R. L. McClelland, R. Detrano et al., “Risk factors for the progression of coronary artery calcification in asymptomatic subjects: results from the Multi-Ethnic Study of Atherosclerosis (MESA),” Circulation, vol. 115, no. 21, pp. 2722–2730, 2007. View at Publisher · View at Google Scholar · View at Scopus
  63. N. Lehmann, S. Möhlenkamp, A. A. Mahabadi et al., “Effect of smoking and other traditional risk factors on the onset of coronary artery calcification: results of the Heinz Nixdorf recall study,” Atherosclerosis, vol. 232, no. 2, pp. 339–345, 2014. View at Publisher · View at Google Scholar · View at Scopus
  64. E. Maffei, G. Messalli, C. Martini et al., “Left and right ventricle assessment with Cardiac CT: validation study vs. Cardiac MR,” European Radiology, vol. 22, no. 5, pp. 1041–1049, 2012. View at Publisher · View at Google Scholar · View at Scopus
  65. M. J. Budoff, D. Dowe, J. G. Jollis et al., “Diagnostic performance of 64-multidetector row coronary computed tomographic angiography for evaluation of coronary artery stenosis in individuals without known coronary artery disease: results from the prospective multicenter ACCURACY (Assessment by Coronary Computed Tomographic Angiography of Individuals Undergoing Invasive Coronary Angiography) trial,” Journal of the American College of Cardiology, vol. 52, no. 21, pp. 1724–1732, 2008. View at Publisher · View at Google Scholar · View at Scopus
  66. F. Cademartiri, E. Maffei, A. Palombo et al., “Clinical application of multi-detector computer tomography coronary angiography review,” Cardioangiologica, vol. 57, no. 3, pp. 349–357, 2009. View at Google Scholar
  67. E. Maffei, S. Seitun, A. I. Guaricci, and F. Cademartiri, “Chest pain: Coronary CT in the ER,” British Journal of Radiology, vol. 89, no. 1061, Article ID 20150954, 2016. View at Publisher · View at Google Scholar · View at Scopus
  68. J. Schulman-Marcus, R. Heo, H. Gransar et al., “Subclinical atherosclerosis detected by coronary computed tomographic angiography in Qatar: a comparison between Qataris and south Asian migrants,” The International Journal of Cardiovascular Imaging, vol. 33, no. 6, pp. 927–935, 2017. View at Publisher · View at Google Scholar · View at Scopus
  69. S. Achenbach, D. Ropers, F. K. Pohle et al., “Detection of coronary artery stenoses using multi-detector CT with 16 x 0.75 collimation and 375 ms rotation,” European Heart Journal, vol. 26, no. 19, pp. 1978–1986, 2005. View at Google Scholar
  70. A. I. Guaricci, E. Maffei, N. D. Brunetti et al., “Heart rate control with oral ivabradine in computed tomography coronary angiography: a randomized comparison of 7.5 mg vs 5 mg regimen,” International Journal of Cardiology, vol. 168, no. 1, pp. 362–368, 2013. View at Publisher · View at Google Scholar · View at Scopus
  71. A. I. Guaricci, J. D. Schuijf, F. Cademartiri et al., “Incremental value and safety of oral ivabradine for heart rate reduction in computed tomography coronary angiography,” International Journal of Cardiology, vol. 156, no. 1, pp. 28–33, 2012. View at Publisher · View at Google Scholar · View at Scopus
  72. G. Pontone, D. Andreini, E. Bertella et al., “Impact of an intra-cycle motion correction algorithm on overall evaluability and diagnostic accuracy of computed tomography coronary angiography,” European Radiology, vol. 26, no. 1, pp. 147–156, 2016. View at Publisher · View at Google Scholar · View at Scopus
  73. T. Arcadi, E. Maffei, C. Mantini et al., “Coronary CT angiography using iterative reconstruction vs. Filtered back projection: Evaluation of image quality,” Acta Biomedica, vol. 86, no. 1, pp. 77–85, 2015. View at Google Scholar · View at Scopus
  74. E. Maffei, C. Martini, S. De Crescenzo et al., “Low dose CT of the heart: a quantum leap into a new era of cardiovascular imaging,” La Radiologia Medica, vol. 115, no. 8, pp. 1179–1207, 2010. View at Publisher · View at Google Scholar · View at Scopus
  75. G. Pontone, D. Andreini, A. Baggiano et al., “Functional relevance of coronary artery disease by cardiac magnetic resonance and cardiac computed tomography: myocardial perfusion and fractional flow reserve,” BioMed Research International, vol. 2015, Article ID 297696, 2015. View at Publisher · View at Google Scholar · View at Scopus
  76. G. Pontone, D. Andreini, A. I. Guaricci et al., “Rationale and design of the PERFECTION (comparison between stress cardiac computed tomography PERfusion versus Fractional flow rEserve measured by Computed Tomography angiography In the evaluation of suspected cOroNary artery disease) prospective study,” Journal of Cardiovascular Computed Tomography, vol. 10, no. 4, pp. 330–334, 2016. View at Publisher · View at Google Scholar · View at Scopus
  77. A. I. Guaricci, “The frontier of the comprehensive information of the coronary plaque together with functional assessment is at the gates,” in Proceedings of the Sep 1, vol. 242:15, pp. 10–1016, 2017.
  78. G. Pontone, P. Carità, M. Verdecchia et al., “Fractional flow reserve: lessons from PLATFORM and future perspectives,” Minerva Cardioangiologica, vol. 65, no. 3, pp. 235–251, 2017. View at Google Scholar
  79. G. Pontone, G. Muscogiuri, and D. Andreini, “The New Frontier of Cardiac Computed Tomography Angiography: fractional Flow Reserve and Stress Myocardial Perfusion,” Current Treatment Options in Cardiovascular Medicine, vol. 18, no. 12, 2016. View at Google Scholar
  80. G. Pontone, E. Bertella, S. Mushtaq et al., “Coronary artery disease: diagnostic accuracy of CT coronary angiography-a comparison of high and standard spatial resolution scanning,” Radiology, vol. 271, no. 3, pp. 688–694, 2014. View at Publisher · View at Google Scholar · View at Scopus
  81. E. Maffei, S. Seitun, C. Martini et al., “Prognostic value of CT coronary angiography in diabetic and non-diabetic subjects with suspected CAD: importance of presenting symptoms,” Insights Imaging, vol. 2, no. 1, pp. 25–38, 2011. View at Google Scholar
  82. G. Pundziute, J. D. Schuijf, J. W. Jukema et al., “Noninvasive assessment of plaque characteristics with multislice computed tomography coronary angiography in symptomatic diabetic patients,” Diabetes Care, vol. 30, no. 5, pp. 1113–1119, 2007. View at Publisher · View at Google Scholar · View at Scopus
  83. E. Maffei, S. Seitun, K. Nieman et al., “Assessment of coronary artery disease and calcified coronary plaque burden by computed tomography in patients with and without diabetes mellitus,” European Radiology, vol. 21, no. 5, pp. 944–953, 2011. View at Publisher · View at Google Scholar · View at Scopus
  84. G. De Backer, E. Ambrosioni, K. Borch-Johnsen et al., “European guidelines on cardiovascular disease prevention in clinical practice: third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in clinical practice,” European Heart Journal, vol. 24, no. 17, pp. 1601–1610, 2003. View at Publisher · View at Google Scholar · View at Scopus
  85. A. I. Guaricci and G. Pontone, “Toward a better selection of the asymptomatic patients worthy for screening of CAD: is it time for an update of the guidelines?” International Journal of Cardiology, vol. 234, p. 135, 2017. View at Publisher · View at Google Scholar · View at Scopus
  86. J. K. Min, T. M. Labounty, and M. J. Gomez, “Incremental prognostic value of coronary computed tomographic angiography over coronary artery calcium score for risk prediction of major adverse cardiac events in asymptomatic diabetic individuals,” Atherosclerosis, vol. 232, pp. 298–304, 2014. View at Publisher · View at Google Scholar
  87. D. A. Halon, M. Azencot, R. Rubinshtein, B. Zafrir, M. Y. Flugelman, and B. S. Lewis, “Coronary computed tomography (CT) angiography as a predictor of cardiac and noncardiac vascular events in asymptomatic type 2 diabetics: a 7-year population-based cohort study,” Journal of the American Heart Association, vol. 5, no. 6, Article ID e003226, 2016. View at Publisher · View at Google Scholar · View at Scopus
  88. M. P. Ostrom, A. Gopal, N. Ahmadi et al., “Mortality Incidence and the Severity of Coronary Atherosclerosis Assessed by Computed Tomography Angiography,” Journal of the American College of Cardiology, vol. 52, no. 16, pp. 1335–1343, 2008. View at Publisher · View at Google Scholar · View at Scopus
  89. M. Hadamitzky, B. Freißmuth, T. Meyer et al., “Prognostic Value of Coronary Computed Tomographic Angiography for Prediction of Cardiac Events in Patients With Suspected Coronary Artery Disease,” JACC: Cardiovascular Imaging, vol. 2, no. 4, pp. 404–411, 2009. View at Publisher · View at Google Scholar · View at Scopus
  90. J. D. Schuijf, J. J. Bax, J. W. Jukema et al., “Noninvasive angiography and assessment of left ventricular function using multislice computed tomography in patients with type 2 diabetes,” Diabetes Care, vol. 27, no. 12, pp. 2905–2910, 2004. View at Publisher · View at Google Scholar · View at Scopus
  91. W. B. Meijboom, M. F. Meijs, J. D. Schuijf et al., “Diagnostic accuracy of 64-slice computed tomography coronary angiography: a prospective, multicenter, multivendor study,” Journal of the American College of Cardiology, vol. 52, no. 25, pp. 2135–2144, 2008. View at Publisher · View at Google Scholar · View at Scopus
  92. J.-J. Kim, B.-H. Hwang, I. J. Choi et al., “Impact of diabetes duration on the extent and severity of coronary atheroma burden and long-term clinical outcome in asymptomatic type 2 diabetic patients: evaluation by coronary CT angiography,” European Heart Journal—Cardiovascular Imaging, vol. 16, no. 10, pp. 1065–1073, 2015. View at Publisher · View at Google Scholar · View at Scopus
  93. J. B. Muhlestein, D. L. Lappé, J. A. C. Lima et al., “Effect of screening for coronary artery disease using CT angiography on mortality and cardiac events in high-risk patients with diabetes: the FACTOR-64 randomized clinical trial,” Journal of the American Medical Association, vol. 312, no. 21, pp. 2234–2243, 2014. View at Publisher · View at Google Scholar · View at Scopus
  94. S. H. Kang, G.-M. Park, S.-W. Lee et al., “Long-Term Prognostic Value of Coronary CT Angiography in Asymptomatic Type 2 Diabetes Mellitus,” JACC: Cardiovascular Imaging, vol. 9, no. 11, pp. 1292–1300, 2016. View at Publisher · View at Google Scholar · View at Scopus
  95. C. Celeng, P. Maurovich-Horvat, B. B. Ghoshhajra, B. Merkely, T. Leiner, and R. A. P. Takx, “Prognostic value of coronary computed tomography angiography in patients with diabetes: a meta-analysis,” Diabetes Care, vol. 39, no. 7, pp. 1274–1280, 2016. View at Publisher · View at Google Scholar · View at Scopus
  96. S. Motoyama, H. Ito, M. Sarai et al., “Plaque characterization by coronary computed tomography angiography and the likelihood of acute coronary events in mid-term follow-up,” Journal of the American College of Cardiology, vol. 66, no. 4, pp. 337–346, 2015. View at Publisher · View at Google Scholar · View at Scopus
  97. A. I. Guaricci, T. Arcadi, N. D. Brunetti et al., “Carotid intima media thickness and coronary atherosclerosis linkage in symptomatic intermediate risk patients evaluated by coronary computed tomography angiography,” International Journal of Cardiology, vol. 176, no. 3, pp. 988–993, 2014. View at Publisher · View at Google Scholar · View at Scopus
  98. A. I. Guaricci, G. Pontone, and L. Fusini, “Additional value of inflammatory biomarkers and carotid artery disease in prediction of significantcoronary artery disease as assessed by coronary computed tomography angiography,” European Heart Journal-Cardiovascular Imaging, vol. 14, no. Oct 14, 2016. View at Google Scholar
  99. J. L. Rosenzweig, E. Ferrannini, S. M. Grundy et al., “Primary prevention of cardiovascular disease and type 2 diabetes in patients at metabolic risk: an endocrine society clinical practice guideline,” The Journal of Clinical Endocrinology & Metabolism, vol. 93, no. 10, pp. 3671–3689, 2008. View at Publisher · View at Google Scholar · View at Scopus
  100. R. J. Stevens, V. Kothari, A. I. Adler, I. M. Stratton, and R. R. Holman, “The UKPDS risk engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS 56),” Clinical Science, vol. 101, no. 6, pp. 671–679, 2001. View at Publisher · View at Google Scholar · View at Scopus
  101. J. Cederholm, K. Eeg-Olofsson, B. Eliasson, B. Zethelius, P. M. Nilsson, and S. Gudbjörnsdottir, “Risk prediction of cardiovascular disease in type 2 diabetes,” Diabetes Care, vol. 31, no. 10, pp. 2038–2043, 2008. View at Publisher · View at Google Scholar · View at Scopus
  102. D. V. Anand, E. Lim, A. Lahiri, and J. J. Bax, “The role of non-invasive imaging in the risk stratification of asymptomatic diabetic subjects,” European Heart Journal, vol. 27, no. 8, pp. 905–912, 2006. View at Publisher · View at Google Scholar · View at Scopus
  103. A. C. Dimitriu-Leen, A. J. H. A. Scholte, A. R. Van Rosendael et al., “Value of coronary computed tomography angiography in tailoring aspirin therapy for primary prevention of atherosclerotic events in patients at high risk with diabetes mellitus,” American Journal of Cardiology, vol. 117, no. 6, pp. 887–893, 2016. View at Publisher · View at Google Scholar · View at Scopus
  104. G. Davì and C. Patrono, “Platelet activation and atherothrombosis,” The New England Journal of Medicine, vol. 357, no. 24, pp. 2482–2494, 2007. View at Publisher · View at Google Scholar · View at Scopus
  105. M. G. Silverman, M. J. Blaha, M. J. Budoff et al., “Potential implications of coronary artery calcium testing for guiding aspirin use among asymptomatic individuals with diabetes,” Diabetes Care, vol. 35, no. 3, pp. 624–626, 2012. View at Publisher · View at Google Scholar · View at Scopus
  106. J. Belch, A. MacCuish, I. Campbell et al., “The Prevention of Progression of Arterial Disease and Diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease,” British Medical Journal, vol. 337, article a1840, 10 pages, 2008. View at Publisher · View at Google Scholar · View at Scopus
  107. H. Ogawa, M. Nakayama, T. Morimoto et al., “Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial,” Journal of the American Medical Association, vol. 300, no. 18, pp. 2134–2141, 2008. View at Publisher · View at Google Scholar · View at Scopus
  108. F. C. Taylor, M. Huffman, and S. Ebrahim, “Statin therapy for primary prevention of cardiovascular disease,” The Journal of the American Medical Association, vol. 310, no. 22, pp. 2451-2452, 2013. View at Publisher · View at Google Scholar · View at Scopus